These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3524929)

  • 1. Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients.
    van Coevorden A; Stolear JC; Dhaene M; van Herweghem JL; Mockel J
    Clin Nephrol; 1986 Jul; 26(1):48-54. PubMed ID: 3524929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypothalamo-hypophyseo-gonadal axis in individuals with chronic renal insufficiency subjected to hemodialysis].
    Mendoza C; Carreras A; Ruiz E; Ortega E; Hervás J; Osorio C
    Rev Esp Fisiol; 1985 Dec; 41(4):443-6. PubMed ID: 3938041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral testosterone undecanoate in hypogonadal male patients.
    Franchimont P; Kicovic PM; Mattei A; Roulier R
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):313-20. PubMed ID: 102469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact level of dihydrotestosterone on the hypothalamic-pituitary-leydig cell axis in men.
    Cailleux-Bounacer A; Rohmer V; Lahlou N; Lefebvre H; Roger M; Kuhn JM
    Int J Androl; 2009 Feb; 32(1):57-65. PubMed ID: 17931384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of many years of hemodialysis therapy on hypophyseal-gonadal axis function in males with chronic renal insufficiency].
    Starzyk J; Grzeszczak W
    Pol Tyg Lek; 1996 Feb; 51(6-9):79-81. PubMed ID: 8756737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pituitary-testicular evaluation in patients with chronic renal insufficiency in hemodialysis treatment].
    Coppola A; Cuomo G
    Minerva Med; 1990 Jun; 81(6):461-4. PubMed ID: 2113639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
    Szilágyi G; Szabolcs I; Vydra G; Góth M; Irsy G
    Acta Med Hung; 1984; 41(4):175-83. PubMed ID: 6440114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 10 days administration of percutaneous dihydrotestosterone on the pituitary-testicular axis in normal men.
    Kuhn JM; Rieu M; Laudat MH; Forest MG; Pugeat M; Bricaire H; Luton JP
    J Clin Endocrinol Metab; 1984 Feb; 58(2):231-5. PubMed ID: 6363434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral testosterone replacement in Korean patients with PADAM.
    Hong JH; Ahn TY
    Aging Male; 2002 Mar; 5(1):52-6. PubMed ID: 12040976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamo-pituitary-gonadal axis in children with chronic renal failure.
    Oertel PJ; Lichtwald K; Häfner S; Rauh W; Schönberg D; Schärer K
    Kidney Int Suppl; 1983 Nov; 15():S34-9. PubMed ID: 6423876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
    Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
    J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus.
    Lavalle C; Loyo E; Paniagua R; Bermudez JA; Herrera J; Graef A; Gonzalez-Barcena D; Fraga A
    J Rheumatol; 1987 Apr; 14(2):268-72. PubMed ID: 3298648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
    Samojlik E; Veldhuis JD; Wells SA; Santen RJ
    J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled study of effects of epimestrol on the pituitary-testicular axis in normal men.
    Luisi M; Kicóvíc PM; Franchi F
    Reproduccion; 1980; 4(1):77-83. PubMed ID: 6771173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
    Bagatell CJ; Dahl KD; Bremner WJ
    J Androl; 1994; 15(1):15-21. PubMed ID: 8188534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status.
    Haren M; Chapman I; Coates P; Morley J; Wittert G
    Age Ageing; 2005 Mar; 34(2):125-30. PubMed ID: 15596419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.